Your browser doesn't support javascript.
loading
COVID Arm: Delayed Hypersensitivity Reactions to SARS-CoV-2 Vaccines Misdiagnosed as Cellulitis.
Lindgren, Aleksandra L; Austin, Andrea Hui; Welsh, Kathleen M.
Afiliação
  • Lindgren AL; University of Queensland - Ochsner Clinical School, New Orleans, LA, USA.
  • Austin AH; Bay Area Cosmetic Dermatology, San Francisco, CA, USA.
  • Welsh KM; Bay Area Cosmetic Dermatology, San Francisco, CA, USA.
J Prim Care Community Health ; 12: 21501327211024431, 2021.
Article em En | MEDLINE | ID: mdl-34120504
ABSTRACT
The term "COVID arm" has been coined to describe a harmless delayed hypersensitivity reaction occurring approximately a week after administration of the novel SARS-CoV-2 mRNA vaccine. It appears as a red, warm, pruritic, indurated, or swollen area in the vicinity of the vaccine site. These reactions, especially if accompanied by systemic symptoms, have been mistaken for cellulitis. We report 3 cases of COVID arm, 2 of which were mistaken for cellulitis. Distinguishing features of COVID arm from cellulitis include pruritus as a common finding, occurrence approximately a week after vaccination, a lack of progression of symptoms, rapid response to topical steroids, and/or spontaneous resolution usually over 4 to 5 days.Practice Points• Patients receiving SARS-CoV-2 vaccines may experience delayed hypersensitivity reactions characterized by erythema, swelling, and itching occurring near the vaccination site (COVID arm), approximately a week after vaccination.• Clinicians can distinguish SARS-CoV-2 vaccine reactions from cellulitis by the time of onset (approximately a week vs 5 days), by the lack of progression of symptoms, and resolution over 4 to 5 days.• Severe cases of COVID arm may be treated with topical steroids.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas / COVID-19 / Hipersensibilidade Tardia Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas / COVID-19 / Hipersensibilidade Tardia Idioma: En Ano de publicação: 2021 Tipo de documento: Article